Orca Bio Stock
Orca Bio is a late-stage biotechnology company focused on developing high-precision cell therapies for the treatment of cancer, autoimmune diseases, and genetic blood disorders. Founded with the mission to improve patient outcomes while minimizing risks associated with traditional therapies, Orca Bio utilizes a unique manufacturing platform that emphasizes single-cell precision.
Sign up for SecondMarket™ to view the market and buy or sell Orca Bio Stock
Buy + SellSee Orca Bio Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Orca Bio Stock Valuation + Share Prices
View real-time Tape D™ data on Orca Bio stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedOrca Bio Management Team
Director
Alex Kolicich
Co-Founder, Chief Scientific Officer, Director
Nathaniel Fernhoff
Co-Founder, CEO, Director
Ivan Dimov
Director
Jonathan MacQuitty
Co-founder, COO
Jereon Bekaert
Orca Bio Major Investors
NanoDimension Management, Ltd.
NanoDimension Management, Ltd.
Illinois Municipal Retirement Fund (IMRF)
Mubadala Capital
DCVC
8VC
Kaiser Family Foundation
Kaiser Permanente Ventures
Lightspeed Venture Partners